![James Porter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
James R.
Porter worked at Infinity Pharmaceuticals, Inc. from 2002 to 2016 as Vice President-Product Development.
From 2017 to 2026, Dr. Porter was with Nuvalent, Inc., serving as President, Chief Executive Officer & Director from 2020 to 2026.
Dr. Porter completed undergraduate studies at the College of the Holy Cross (Massachusetts) and earned a doctorate from Boston College.
Anciens postes connus de James Porter
| Sociétés | Poste | Fin |
|---|---|---|
| NUVALENT, INC. | Directeur Général | 15/07/2026 |
| INFINITY PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/12/2016 |
Formation de James Porter
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
64
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
College of the Holy Cross (Massachusetts)
 College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Infinity Pharmaceuticals, Inc.
 Infinity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for the treatment of cancer | Health Technology |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuvalent, Inc.
 Nuvalent, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of targeted therapies for patients with cancer | Health Technology |
